Schedule 13G ownership disclosure
Aurinia Pharmaceuticals Inc
Security class unavailable · CUSIP: 05156V102
Event date: 2015-03-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,092,595
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-018400
- Form type
- SC 13G
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Mar 25, 2015
- Reporting period
- Mar 24, 2015
- Description
- Schedule 13G beneficial ownership